Ethical issues in children with cardiomyopathy

Making sense of ethical challenges in the clinical setting

Kristin C. Sokol, F. Daniel Armstrong, Eliot R. Rosenkranz, Daphne T. Hsu, Steven E. Schultz, G. Patricia Cantwell, Marco Ricci, Steven E. Lipshultz

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Although there has been substantial progress in the treatment of cardiomyopathy in children, the field is still evolving and many of the important aspects of cardiomyopathy care remain uncertain. As a result of this uncertainty, parents and health care professionals are often faced with difficult decisions that raise serious ethical concerns. We identify and discuss some of these challenges within the framework of ethics and medical decision making. We address several common issues: (1) Who makes decisions in the case of children and adolescents with cardiomyopathy, and how are these made? (2) How should the effect of a treatment be weighed against consideration of the impact of the treatment on the child's quality of life? (3) How should the limitations of treatment effectiveness and the impact on scarce resources be addressed in children with cardiomyopathy, and (4) What is the role of a pediatric bioethics committee in facilitating decision-making related to cardiomyopathy in children? The patient's health care team must be able to identify and address the ethical considerations that arise in the setting of a child with a disease that has a high risk of progressing towards transplant and possibly an early death. Physicians and other health care professionals who care for children with pediatric cardiomyopathy often face questions related to deciding who should be involved with medical decision making, balancing acute physiologic benefits with considerations of the patient's quality of life and understanding how the concept of futility applies in an otherwise aggressive treatment setting. To aid clinicians with these challenges, we discuss the role of an ethics consultation in the management process of a child with cardiomyopathy.

Original languageEnglish (US)
Pages (from-to)81-87
Number of pages7
JournalProgress in Pediatric Cardiology
Volume23
Issue number1-2
DOIs
StatePublished - Sep 2007
Externally publishedYes

Fingerprint

Cardiomyopathies
Ethics
Patient Care Team
Ethics Consultation
Quality of Life
Pediatrics
Medical Futility
Delivery of Health Care
Bioethics
Therapeutics
Child Care
Uncertainty
Decision Making
Parents
Physicians
Transplants

Keywords

  • Autonomy
  • Ethics
  • Futility
  • Pediatric cardiomyopathy
  • Quality of life

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Sokol, K. C., Armstrong, F. D., Rosenkranz, E. R., Hsu, D. T., Schultz, S. E., Cantwell, G. P., ... Lipshultz, S. E. (2007). Ethical issues in children with cardiomyopathy: Making sense of ethical challenges in the clinical setting. Progress in Pediatric Cardiology, 23(1-2), 81-87. https://doi.org/10.1016/j.ppedcard.2007.05.010

Ethical issues in children with cardiomyopathy : Making sense of ethical challenges in the clinical setting. / Sokol, Kristin C.; Armstrong, F. Daniel; Rosenkranz, Eliot R.; Hsu, Daphne T.; Schultz, Steven E.; Cantwell, G. Patricia; Ricci, Marco; Lipshultz, Steven E.

In: Progress in Pediatric Cardiology, Vol. 23, No. 1-2, 09.2007, p. 81-87.

Research output: Contribution to journalArticle

Sokol, KC, Armstrong, FD, Rosenkranz, ER, Hsu, DT, Schultz, SE, Cantwell, GP, Ricci, M & Lipshultz, SE 2007, 'Ethical issues in children with cardiomyopathy: Making sense of ethical challenges in the clinical setting', Progress in Pediatric Cardiology, vol. 23, no. 1-2, pp. 81-87. https://doi.org/10.1016/j.ppedcard.2007.05.010
Sokol, Kristin C. ; Armstrong, F. Daniel ; Rosenkranz, Eliot R. ; Hsu, Daphne T. ; Schultz, Steven E. ; Cantwell, G. Patricia ; Ricci, Marco ; Lipshultz, Steven E. / Ethical issues in children with cardiomyopathy : Making sense of ethical challenges in the clinical setting. In: Progress in Pediatric Cardiology. 2007 ; Vol. 23, No. 1-2. pp. 81-87.
@article{b7a05f708f8e4f3f954994676ad57f71,
title = "Ethical issues in children with cardiomyopathy: Making sense of ethical challenges in the clinical setting",
abstract = "Although there has been substantial progress in the treatment of cardiomyopathy in children, the field is still evolving and many of the important aspects of cardiomyopathy care remain uncertain. As a result of this uncertainty, parents and health care professionals are often faced with difficult decisions that raise serious ethical concerns. We identify and discuss some of these challenges within the framework of ethics and medical decision making. We address several common issues: (1) Who makes decisions in the case of children and adolescents with cardiomyopathy, and how are these made? (2) How should the effect of a treatment be weighed against consideration of the impact of the treatment on the child's quality of life? (3) How should the limitations of treatment effectiveness and the impact on scarce resources be addressed in children with cardiomyopathy, and (4) What is the role of a pediatric bioethics committee in facilitating decision-making related to cardiomyopathy in children? The patient's health care team must be able to identify and address the ethical considerations that arise in the setting of a child with a disease that has a high risk of progressing towards transplant and possibly an early death. Physicians and other health care professionals who care for children with pediatric cardiomyopathy often face questions related to deciding who should be involved with medical decision making, balancing acute physiologic benefits with considerations of the patient's quality of life and understanding how the concept of futility applies in an otherwise aggressive treatment setting. To aid clinicians with these challenges, we discuss the role of an ethics consultation in the management process of a child with cardiomyopathy.",
keywords = "Autonomy, Ethics, Futility, Pediatric cardiomyopathy, Quality of life",
author = "Sokol, {Kristin C.} and Armstrong, {F. Daniel} and Rosenkranz, {Eliot R.} and Hsu, {Daphne T.} and Schultz, {Steven E.} and Cantwell, {G. Patricia} and Marco Ricci and Lipshultz, {Steven E.}",
year = "2007",
month = "9",
doi = "10.1016/j.ppedcard.2007.05.010",
language = "English (US)",
volume = "23",
pages = "81--87",
journal = "Progress in Pediatric Cardiology",
issn = "1058-9813",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Ethical issues in children with cardiomyopathy

T2 - Making sense of ethical challenges in the clinical setting

AU - Sokol, Kristin C.

AU - Armstrong, F. Daniel

AU - Rosenkranz, Eliot R.

AU - Hsu, Daphne T.

AU - Schultz, Steven E.

AU - Cantwell, G. Patricia

AU - Ricci, Marco

AU - Lipshultz, Steven E.

PY - 2007/9

Y1 - 2007/9

N2 - Although there has been substantial progress in the treatment of cardiomyopathy in children, the field is still evolving and many of the important aspects of cardiomyopathy care remain uncertain. As a result of this uncertainty, parents and health care professionals are often faced with difficult decisions that raise serious ethical concerns. We identify and discuss some of these challenges within the framework of ethics and medical decision making. We address several common issues: (1) Who makes decisions in the case of children and adolescents with cardiomyopathy, and how are these made? (2) How should the effect of a treatment be weighed against consideration of the impact of the treatment on the child's quality of life? (3) How should the limitations of treatment effectiveness and the impact on scarce resources be addressed in children with cardiomyopathy, and (4) What is the role of a pediatric bioethics committee in facilitating decision-making related to cardiomyopathy in children? The patient's health care team must be able to identify and address the ethical considerations that arise in the setting of a child with a disease that has a high risk of progressing towards transplant and possibly an early death. Physicians and other health care professionals who care for children with pediatric cardiomyopathy often face questions related to deciding who should be involved with medical decision making, balancing acute physiologic benefits with considerations of the patient's quality of life and understanding how the concept of futility applies in an otherwise aggressive treatment setting. To aid clinicians with these challenges, we discuss the role of an ethics consultation in the management process of a child with cardiomyopathy.

AB - Although there has been substantial progress in the treatment of cardiomyopathy in children, the field is still evolving and many of the important aspects of cardiomyopathy care remain uncertain. As a result of this uncertainty, parents and health care professionals are often faced with difficult decisions that raise serious ethical concerns. We identify and discuss some of these challenges within the framework of ethics and medical decision making. We address several common issues: (1) Who makes decisions in the case of children and adolescents with cardiomyopathy, and how are these made? (2) How should the effect of a treatment be weighed against consideration of the impact of the treatment on the child's quality of life? (3) How should the limitations of treatment effectiveness and the impact on scarce resources be addressed in children with cardiomyopathy, and (4) What is the role of a pediatric bioethics committee in facilitating decision-making related to cardiomyopathy in children? The patient's health care team must be able to identify and address the ethical considerations that arise in the setting of a child with a disease that has a high risk of progressing towards transplant and possibly an early death. Physicians and other health care professionals who care for children with pediatric cardiomyopathy often face questions related to deciding who should be involved with medical decision making, balancing acute physiologic benefits with considerations of the patient's quality of life and understanding how the concept of futility applies in an otherwise aggressive treatment setting. To aid clinicians with these challenges, we discuss the role of an ethics consultation in the management process of a child with cardiomyopathy.

KW - Autonomy

KW - Ethics

KW - Futility

KW - Pediatric cardiomyopathy

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=34547404151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547404151&partnerID=8YFLogxK

U2 - 10.1016/j.ppedcard.2007.05.010

DO - 10.1016/j.ppedcard.2007.05.010

M3 - Article

VL - 23

SP - 81

EP - 87

JO - Progress in Pediatric Cardiology

JF - Progress in Pediatric Cardiology

SN - 1058-9813

IS - 1-2

ER -